4MOT

Structure of Streptococcus pneumonia pare in complex with AZ13072886

4MOT の概要

• エントリーDOI: 10.2210/pdb4mot/pdb
• 関連するPDBエントリー: 4EM7 4EMV 4MB9 4MBC
• 分子名称: Topoisomerase IV subunit B, 1-[4-(3-methylbutyl)-5-oxo-6-(pyridin-3-yl)-4,5-dihydro[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-prop-2-en-1-ylurea (3 entities in total)
• 機能のキーワード: atp binding, structure-based drug design, antimicrobial, virtual screen, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor
• 由来する生物種: Streptococcus pneumoniae
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 24998.22

構造登録者

Ogg, D.,Boriack-Sjodin, P.A. (登録日: 2013-09-12, 公開日: 2013-11-20, 最終更新日: 2024-02-28)

• 主引用文献: Kale, R.R.,Kale, M.G.,Waterson, D.,Raichurkar, A.,Hameed, S.P.,Manjunatha, M.R.,Kishore Reddy, B.K.,Malolanarasimhan, K.,Shinde, V.,Koushik, K.,Jena, L.K.,Menasinakai, S.,Humnabadkar, V.,Madhavapeddi, P.,Basavarajappa, H.,Sharma, S.,Nandishaiah, R.,Mahesh Kumar, K.N.,Ganguly, S.,Ahuja, V.,Gaonkar, S.,Naveen Kumar, C.N.,Ogg, D.,Boriack-Sjodin, P.A.,Sambandamurthy, V.K.,de Sousa, S.M.,Ghorpade, S.R.; Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy.; Bioorg.Med.Chem.Lett., 24:870-879, 2014; PubMed: 24405701; DOI: 10.1016/j.bmcl.2013.12.080

実験手法

X-RAY DIFFRACTION (1.75 Å)